The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea
- PMID: 28277105
- DOI: 10.1080/09513590.2017.1296948
The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea
Abstract
The induction of ovulation by the means of a pump which assures the pulsatile administration of GnRH is a well-known method that applies to women suffering from amenorrhea of hypothalamic origin. Although a simple and efficient method to establish fertility, it is underused. Twelve patients suffering from this condition, 1 Kallmann syndrome, 4 normosmic isolated hypogonadotropic hypogonadism, and 7 functional hypothalamic amenorrhea desiring pregnancy were treated. They underwent one or more cycles of pulsatile GnRH, at a frequency of 90 minutes, either by the intravenous or the subcutaneous route. An initial dose of 5 μg per pulse in the intravenous route was administered and of 15 μg per pulse in the subcutaneous route. The treatment was monitored by regular dosing of gonadotropins, estradiol and progesterone, and the development of follicles and ovulation was monitored by intra-vaginal ultrasonography. All the patients had documented ovulation, after a mean of 17 days on pump stimulation. Single ovulation occurred in 30 of 33 treatment cycles, irrespective of the route of administration. Ovulation resulted in 10 pregnancies over 7 patients (2 pregnancies in 3 of them), distributed in the 3 diagnostic categories. For comparison, a patient with PCOS treated similarly, disclosed premature LH surge without ovulation.
Keywords: GnRH pump; hypothalamic amenorrhea; ovulation induction.
Similar articles
-
Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.J Clin Endocrinol Metab. 1991 May;72(5):965-72. doi: 10.1210/jcem-72-5-965. J Clin Endocrinol Metab. 1991. PMID: 1902487
-
[Induction of ovulation, with pulsatile GnRH by subcutaneous route in amenorrhea of hypothalamic origin].Ann Endocrinol (Paris). 1990;51(1):33-7. Ann Endocrinol (Paris). 1990. PMID: 2221820 French.
-
Pulsatile gonadotropin-releasing hormone therapy: comparison of efficacy between functional hypothalamic amenorrhea and congenital hypogonadotropic hypogonadism.Fertil Steril. 2025 Feb;123(2):270-279. doi: 10.1016/j.fertnstert.2024.08.354. Epub 2024 Sep 2. Fertil Steril. 2025. PMID: 39233038
-
[Ovulation induction by pulsatile GnRH therapy in 2014: literature review and synthesis of current practice].Gynecol Obstet Fertil. 2014 Oct;42(10):732-40. doi: 10.1016/j.gyobfe.2014.07.017. Epub 2014 Sep 22. Gynecol Obstet Fertil. 2014. PMID: 25245838 Review. French.
-
Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis.Fertil Steril. 2018 Apr;109(4):708-719.e8. doi: 10.1016/j.fertnstert.2017.12.028. Epub 2018 Mar 28. Fertil Steril. 2018. PMID: 29605411
Cited by
-
Pituitary gonadotroph-specific patterns of gene expression and hormone secretion.Curr Opin Pharmacol. 2022 Oct;66:102274. doi: 10.1016/j.coph.2022.102274. Epub 2022 Aug 19. Curr Opin Pharmacol. 2022. PMID: 35994915 Free PMC article. Review.
-
The effects of weight loss-related amenorrhea on women's health and the therapeutic approaches: a narrative review.Ann Transl Med. 2023 Jan 31;11(2):132. doi: 10.21037/atm-22-6366. Ann Transl Med. 2023. PMID: 36819572 Free PMC article. Review.
-
Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea.J Clin Res Pediatr Endocrinol. 2020 Feb 6;12(Suppl 1):18-27. doi: 10.4274/jcrpe.galenos.2019.2019.S0178. J Clin Res Pediatr Endocrinol. 2020. PMID: 32041389 Free PMC article. Review.
-
Diagnosis and Management of Infertility: A Review.JAMA. 2021 Jul 6;326(1):65-76. doi: 10.1001/jama.2021.4788. JAMA. 2021. PMID: 34228062 Free PMC article. Review.
-
Hypothalamic-Pituitary-Gonadal Axis Disorders Impacting Fertility in Both Sexes and the Potential of Kisspeptin-Based Therapies to Treat Them.Handb Exp Pharmacol. 2023;282:259-288. doi: 10.1007/164_2023_666. Handb Exp Pharmacol. 2023. PMID: 37439848
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical